natgillin/translations-raw huggingface dataset:
It is available as 4 g sachets containing ‘gastro- resistant’ granules that allow the active substance to reach the intestine without being released in the stomach, thus reducing side effects in the stomach.
Lijek je dostupan u vrećicama od 4 g koje sadrže „gastro rezistentne” granule koje omogućuju djelatnoj tvari da dospije u crijeva bez otpuštanja u želucu, te se na taj način smanjuju nuspojava u želucu.
It is available as 400 mg tablets, 25 and 100 mg chewable tablets and granules for an oral suspension (in sachets, each containing 100mg)..
Dostupan je kao tablete od 400 mg, tablete za žvakanje od 25 i 100 mg te kao granule za oralnu suspenziju (u vrećicama, svaka sadrži 100 mg).
It is available as a concentrate and a solvent to be made up into a solution for infusion (drip) into a vein.
Dostupan je kao prašak i otapalo za koncentrat za otopinu za infuziju (drip) u venu.
It is available as a concentrate that is made up into a solution for infusion (drip) into a vein.
Dostupan je kao koncentrat za otopinu za infuziju (drip) u venu.
It is available as a concentrate that is made up into a solution for infusion (drip) into a vein.
Postoji kao koncentrat za suspenziju za infuziju (drip u venu).
It is available as a concentrate to be made into a solution for infusion (drip) into a vein.
Lijek je dostupan kao koncentrat za pripremu otopine za infuziju (drip) u venu.
It is available as a concentrate to be made into a solution for infusion (drip) into a vein.
Postoji kao koncentrat za otopinu za infuziju (drip) u venu.
It is available as a powder (150 mg) that is made up into a solution for injection.
Dostupan je kao prašak (150 mg) za otopinu za injekciju.
It is available as a powder and a solvent to be made up into a solution for injection.
Dostupan je kao prašak i otapalo za otopinu za injekciju.
It is available as a powder and solvent that are made up into a suspension for injection.
Dostupno je u obliku praška i otapala koje se miješaju u suspenziju za injekciju.
It is available as a powder and solvent that are mixed together to make a prolonged-release suspension for injection that provides 2 mg of exenatide.
Dostupan je kao prašak i otapalo koji se miješaju kako bi se dobila suspenzija s produljenim oslobađanjem za injekciju kojom se osigurava 2 mg eksenatida.
It is available as a powder and solvent used to make a solution for injection.
Dostupan je u obliku praška i otapala za otopinu za injekciju.
It is available as a powder that is made up into a solution for infusion (drip) into a vein and as a solution for injection under the skin in pre-filled syringes and pre-filled pens.
Dostupan je kao prašak za pripremu otopine za infuziju (drip) u venu i kao otopina za injekciju pod kožu u napunjenim štrcaljkama i napunjenim brizgalicama.
It is available as a powder to make up a solution for injection, and is injected by a healthcare professional under the skin of the upper arm, thigh or abdomen (belly) once every 4 weeks.
Dostupna je u obliku praška za otopinu za injekciju koju primjenjuje zdravstveni djelatnik u nadlakticu, bedro ili abdomen (trbuh) jednom svaka 4 tjedna.
It is available as a pre-filled syringe (100 and 150 micrograms).
Dostupna je kao napunjena štrcaljka (100 i 150 mikrograma).
It is available as a premix for medicated feeding stuff for pigs (0.5%, 10% and 50%) and rabbits (10%), and as an oral powder for pigs (10%).
Dostupan je kao predmješavina za ljekovitu hranu za svinje (0,5%, 10% i 50%) i zečeve (10%) te kao oralni prašak za svinje (10%).
It is available as a solution for infusion (drip) into a vein (100 mg/ml).
Dostupan je kao otopina za infuziju (drip) u venu (100 mg/ml).
It is available as a solution for infusion (drip) to be given into a vein.
Dostupan je kao otopina za infuziju (drip) koja se daje u venu.
It is available as a solution for injection in a pre-filled syringe or pre-filled pen, and a vial for use in children only, all containing 40 mg adalimumab.
Dostupan je kao otopina za injekciju u napunjenoj štrcaljki ili napunjenoj brizgalici i kao bočica isključivo za primjenu u djece, a sve sadrže 40 mg adalimumaba.
It is available as a solution for injection in prefilled syringes or vials.
Dostupan je kao otopina za injekcije u napunjenim štrcaljkama ili bočicama.
It is available as a solution for injection in vials (135 and 180 micrograms), pre-filled syringes (90, 135 and 180 micrograms) and pre-filled pens (135 and 180 micrograms).
Dostupan je kao otopina za injekcije u bočicama (135 i 180 mikrograma), napunjenim špricama (90, 135 i 180 mikrograma) i napunjenim brizgalicama (135 i 180 mikrograma).
It is available as a solution for injection into the eye in pre-filled syringes or vials.
Dostupan je kao otopina za injekcije za oko u napunjenim štrcaljkama ili bočicama.
It is available as a solution for injection under the skin (0.3 mg, 0.6 mg and 0.9 mg) or as a powder and solvent to make up a suspension for injection into the muscle (20 mg, 40 mg and 60 mg).
Dostupan je kao otopina za supkutanu injekciju (0,3 mg, 0,6 mg i 0,9 mg) ili kao prašak i otopina za pripremu suspenzije za injekciju u mišić (20 mg, 40 mg i 60 mg).
It is available as a spot-on solution in an applicator for use on cats.
Dostupan je kao otopina za nakapavanje u aplikatoru za primjenu u mačaka.
It is available as a spot-on solution in applicators of five different strengths for use on dogs of different weights.
Dostupan je kao otopina za nakapavaje u aplikatorima od pet različitih jačina za primjenu u pasa različitih težina.
It is available as a spot-on solution in applicators of two different strengths for use in cats of various bodyweights.
Dostupan je kao spot-on otopina u aplikatorima dvije različite jačine za primjenu u mačaka različitih tjelesnih težina.
It is available as a suspension for injection (40 IU/ml).
Dostupan je kao suspenzija za injekciju (40 IU/ml).
It is available as a suspension for injection that contains parts of the bacterium
Dostupan je kao suspenzija za injekciju koja sadrži dijelove bakterije
It is available as a suspension for injection that contains some parts of inactivated (killed) influenza (flu) virus.
Dostupno je u obliku suspenzije za injekciju koja sadrži neke dijelove inaktiviranog (ubijenog) virusa influence (gripe).
It is available as a ‘spot-on’ solution in pipettes already filled with the correct amount needed to treat one dog depending on its weight.
Dostupan je kao otopina za nakapavanje na kožu u pipetama već napunjenima ispravnom količinom potrebnom za liječenje pasa ovisno o težini.
It is available as an inhalation powder in a portable inhaler device; each inhalation provides a fixed dose of the medicine.
Dostupan je kao prašak za inhalaciju u prijenosnom inhalatoru; svaka inhalacija osigurava utvrđenu dozu lijeka.
It is available as an oral solution (1 mg/ml) and tablets (0.5 mg, 1 mg and 2 mg).
Dostupan je kao oralna otopina (1 mg/ml) i tablete (0,5 mg, 1 mg i 2 mg).
It is available as an oral suspension (200 mg/ml) for use in drinking water for pigs and chickens.
Dostupan je kao oralna suspenzija (200 mg/ml) za primjenu u vodi za piće za svinje i kokoši.
It is available as capsules (0.5 mg).
Dostupan je u obliku kapsula (0,5 mg).
It is available as capsules (2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg and 25 mg).
Dostupan je u kapsulama (2,5 mg, 5 mg, 7,5 mg, 10 mg, 15 mg, 20 mg i 25 mg).
It is available as capsules (200 mg and 250 mg).
Dostupan je u obliku kapsula (200 mg i 250 mg).
It is available as capsules (200 mg) and tablets (500 mg).
Dostupan je u obliku kapsula (od 200 mg) i tableta (od 500 mg).
It is available as capsules (267 mg).
Dostupan je kao kapsule (267 mg).
It is available as capsules (50 mg).
Dostupan je u obliku kapsula (50 mg).
It is available as capsules (50, 100, 200 mg) and as tablets (600 mg).
Dostupan je u obliku kapsula (50, 100 i 600 mg).
It is available as capsules (50, 100, 200 mg), as tablets (50, 200 and 600 mg), and as an oral solution (30 mg/ml).
Dostupan je u obliku kapsula (50, 100, 200 mg), tableta (50, 200 i 600 mg) i oralne otopine (30 mg/ml).
It is available as capsules (75, 110 and 150 mg).
Dostupan je u obliku kapsula (75, 110 i 150 mg).
It is available as chewable tablets in five different strengths for use in dogs of different weights.
Dostupan je kao tablete za žvakanje u pet različitih jačina za primjenu u pasa različitih tjelesnih težina.
It is available as chewable tablets in four different strengths for use in dogs of different weights.
Dostupan je kao tablete za žvakanje u četiri različite jačine za primjenu u pasa različitih težina.
It is available as film-coated tablets (90, 180 and 360 mg) and as dispersible tablets (125, 250 and 500 mg).
Lijek je dostupan u obliku filmom obloženih tableta (od 90, 180 i 360 mg) i tableta za oralnu suspenziju (od 125, 250 i 500 mg).
It is available as immediate- release tablets (0.088 mg, 0.18 mg, 0.35 mg, 0.7 mg and 1.1 mg) and prolonged-release tablets (0.26 mg, 0.52 mg, 1.05 mg, 1.57 mg, 2.1 mg, 2.62 mg and 3.15 mg).
Dostupan je u obliku tableta s neposrednim oslobađanjem (0,088 mg, 0,18 mg, 0,35 mg, 0,7 mg i 1,1 mg) te u obliku tableta s produljenim oslobađanjem (0,26 mg, 0,52 mg, 1,05 mg, 1,57 mg, 2,1 mg, 2,62 mg i 3,15 mg).
It is available as soluble tablets (100 mg).
Dostupan je kao topive tablete (100 mg).
It is available as tablets (12.5, 25, 50 and 75 mg).
Dostupan je u obliku tableta (12,5, 25, 50 i 75 mg).
It is available as tablets (123, 163, 204 and 245 mg) and as granules (33 mg/g).
Dostupan je u obliku tableta (123, 163, 204 i 245 mg) i granula (33 mg/g).
It is available as tablets (150 and 500 mg).
Dostupan je u tabletama (150 i 500 mg).
It is available as tablets (150 mg aliskiren and 12.5 mg hydrochlorothiazide; 150 mg aliskiren and 25 mg hydrochlorothiazide; 300 mg aliskiren and 12.5 mg hydrochlorothiazide; 300 mg aliskiren and 25 mg hydrochlorothiazide).
Dostupan je u tabletama (150 mg aliskirena i 12,5 mg hidroklorotiazida; 150 mg aliskirena i 25 mg hidroklorotiazida; 300 mg aliskirena i 12,5 mg hidroklorotiazida; 300 mg aliskirena i 25 mg hidroklorotiazida).
It is available as tablets (150 mg) and as granules (50 mg and 75 mg) in a sachet.
Dostupan je u obliku tableta (150 mg) i granula (50 mg i 75 mg) u vrećici.
It is available as tablets (2.5 mg, 5 mg).
Dostupan je kao tablete (2,5 mg, 5 mg).
It is available as tablets (2.5, 5 and 10 mg) and as dispersible tablets (2, 3 and 5 mg).
Dostupan je u tabletama (2,5 mg, 5 mg i 10 mg) i tabletama za oralnu suspenziju (2 mg, 3 mg i 5 mg).
It is available as tablets (2.5, 5 and 10 mg).
Dostupan je u obliku tableta (od 2,5, 5 i 10 mg).
It is available as tablets (20, 50, 70, 80, 100 and 140 mg).
Dostupan je kao tablete (20, 50, 70, 80, 100 i 140 mg).
It is available as tablets (25 mg).
Dostupan je u tabletama (25 mg).
It is available as tablets (25, 100 and 150 mg).
Dostupan je u obliku tableta (od 25, 100 i 150 mg).
It is available as tablets (25, 100 and 200 mg).
Dostupan je kao tablete (25, 100 i 200 mg).
It is available as tablets (250 mg).
Dostupan je u tabletama (250 mg).
It is available as tablets (5 mg).
Dostupan je u obliku tableta od (5 mg).
It is available as tablets (5 mg, 10 mg, 15 mg and 30 mg), orodispersible tablets (tablets that dissolve in the mouth; 10, 15 and 30 mg), an oral solution (1 mg/ml) and a solution for injection (7.5 mg/ml).
Dostupan je u obliku tableta (5 mg, 10 mg, 15 mg i 30 mg), raspadljivih tableta za usta (tablete koje se otapaju u ustima; 10, 15 i 30 mg), u obliku oralnih otopina (1 mg/ml) i otopina za injekcije (7,5 mg/ml).
It is available as tablets (500 and 1,000 mg) and as an oral solution (100 mg/ml).
Dostupan je u obliku tableta (150 i 1 000 mg) te kao oralna otopina (100 mg/ml).
It is available as ‘buccal tablets’ (tablets that dissolve in the mouth).
Dostupan je kao „bukalne tablete” (tablete koje se tope u ustima).
It is available as ‘film-coated’ tablets (62.5 mg; 125 mg) and as dispersible tablets (32 mg).
Dostupan je u obliku „filmom obložene“ tablete (62.5 mg; 125 mg) i disperzivne tablete (32 mg).
It is available in 6 × 1 tablets in perforated unit-dose blisters.
Lijek je dostupan u perforiranim blisterima djeljivima na jedinične doze sa 6 × 1 tableta.
It is available in a pre-filled syringe (200 mg/ml).
Dostupan je kao napunjena štrcaljka (200 mg/ml).
It is available in blisters in pack sizes of 30 and 60 tablets and in glass bottles in pack sizes of 30, 60 ,100 and 200 film- coated tablets.
Dostupne su u blisterima u veličinama pakiranja od 30 i 60 tableta te u staklenim bočicama u veličinama pakiranja od 30, 60, 100 i 200 filmom obloženih tableta.
It is available in pack size of 1, 2 or 6 pre-filled syringes.
Dostupna je u pakiranjima od 1, 2 ili 6 napunjenih štrcaljki.
It is available in pack sizes of 4 single-dose kits and 3 packs of 4 single-dose kits.
Lijek je dostupan u veličinama pakiranja od 4 jednodozna seta i 3 pakiranja sa 4 jednodozna seta.
It is available in packs containing 1 pre-filled syringe.
Lijek je dostupan u pakiranju s 1 napunjenom štrcaljkom.
It is available in packs containing either 1 or 5 vials; each vial contains 1 mg or 4 mg of topotecan.
Dostupan je u kutiji s 1 ili 5 bočica; jedna bočica sadrži 1 mg ili 4 mg topotekana.
It is available in packs of 1 vial of 50 mL
Dostupan je u pakiranjima od 1 bočice volumena 50 ml.
It is available in packs of 2, 7, 10 and 20 pre-filled syringes (not all pack sizes may be marketed).
Dostupna je u pakiranju s 2,7,10 i 20 napunjenih štrcaljki (na tržištu se ne moraju nalaziti sve veličine pakiranja).
It is available in packs of 4 vials.
Dostupan je u pakiranjima od 4 bočice.
It is available in packs of one or seven vials (not all pack sizes may be marketed).
Dostupan je u pakiranjima od jedne ili sedam bočica (na tržištu se ne moraju nalaziti sve veličine pakiranja).
It is available in packs of:
Dostupna je u pakiranjima od:
It is available in pre-filled pens (6 mg/ml).
Dostupna je u prethodno napunjenim brizgalicama (6 mg/ml).
It is available in pre-filled syringes that contain between 1,000 and 40,000 international units (IU) of the active substance, epoetin alfa.
Dostupan je u napunjenim štrcaljkama koje sadrže između 1000 i 40 000 internacionalnih jedinica (IU) djelatne tvari, epoetin alfe.
It is available in prefilled syringes or in vials, each of which contains 60 mg denosumab.
Lijek je dostupan u napunjenoj štrcaljki ili bočici koje sadrže 60 mg denosumaba.
It is available in single- use vials containing 120 mg denosumab.
Dostupna je u jednokratnim bočicama koje sadrže 120 mg denosumaba.
It is available in single-dose containers and in multidose containers.
Dostupan je u jednodoznim spremnicima i višedoznim spremnicima.
It is available in vials or in prefilled syringes.
Dostupan je u bočicama ili kao napunjene štrcaljke.
It is believed that these symptoms are due to a recovery of the body’s immune system.
Vjeruje se da su ti simptomi posljedica oporavka imunološkog sustava organizma.
It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Pretpostavlja se da se ti simptomi javljaju zbog poboljšanja u odgovoru imunološkog sustava omogućavajući organizmu da se bori protiv infekcije koja je bila prisutna bez jasnih simptoma.
It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Smatra se da ovi simptomi nastaju zbog poboljšanja imunološke reakcije tijela, omogućujući tijelu da se bori protiv infekcija koje mogu biti prisutne bez vidljivih simptoma.
It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Smatra se da su ti simptomi posljedica poboljšanja imunološkog odgovora koji omogućava tijelu da se bori protiv infekcija koje su možda bile prisutne bez vidljivih simptoma.
It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Smatra se da su ti simptomi posljedica poboljšanog imunološkog odgovora kojim se tijelo bori protiv infekcija koje su možda bile prisutne bez vidljivih simptoma.
It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Vjeruje se da su ti simptomi posljedica poboljšanja tjelesnog imunološkog odgovora, koje omogućava tijelu da se bori protiv infekcija koje mogu biti prisutne bez jasnih simptoma.
It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Vjeruje se da su ti simptomi posljedica poboljšanog imunološkog odgovora koji omogućuje da se tijelo bori protiv infekcija koje su možda bile prisutne bez vidljivih simptoma.
It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Vjeruje se da su ti simptomi posljedica poboljšanog imunološkog odgovora, koji omogućuje da se tijelo bori protiv infekcija koje su možda bile prisutne bez vidljivih simptoma.
It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Vjeruje se da su ti znakovi posljedica oporavka imunološkog odgovora organizma koji omogućava organizmu da se bori protiv infekcija, koje su vjerojatno i ranije bile prisutne bez vidljivih simptoma.
It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Vjeruje se da ti simptomi nastaju zbog poboljšanja imunog odgovora tijela, koji tijelu omogućuje da se bori protiv infekcija koje su možda bile prisutne bez očitih simptoma.
It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Vjeruje se da ti simptomi nastaju zbog poboljšanja imunološkog odgovora organizma koje omogućava da se tijelo bori s infekcijama koje su mogle biti prisutne bez vidljivih simptoma.
It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Vjeruje se da ti simptomi nastaju zbog poboljšanja imunološkog odgovora organizma, osposobljavajući organizam za borbu protiv infekcija koje bi mogle biti prisutne bez vidljivih simptoma.
It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Vjeruje se da ti simptomi nastaju zbog poboljšanja imunosnog odgovora organizma koji tijelu omogućuje borbu protiv infekcija koje su možda bile prisutne bez vidljivih simptoma.
It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Vjeruje se da ti simptomi nastaju zbog poboljšanog imunološkog odgovora organizma, što tijelu omogućuje da se bori protiv infekcija koje su mogle biti prisutne i bez vidljivih simptoma.
It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Vjeruje se da ti simptomi nastaju zbog poboljšanog imunološkog odgovora tijela, koji tijelu omogućuje da se bori protiv infekcija koje su možda prisutne bez očitih simptoma.
It is believed that these symptoms are due to improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Vjeruje se da je uzrok tih simptoma poboljšanje imunološkog odaziva tijela koje tijelu omogućava da se bori protiv infekcija koje su možda bile prisutne bez pojave očitih simptoma.
It is best to have an interval as close as possible to 12 hours between doses, but this interval must be at least 6 hours.
Najbolje je održavati razmak između doza što je bliže 12 sati, no ovaj razmak mora biti najmanje 6 sati.
It is best to leave close to 12 hours between doses, but this must be at least 6 hours
Najbolje je da prođe blizu 12 sati između doza, ali razmak mora biti najmanje 6 sati.
It is best to measure your blood sugar level regularly, to get the maximum benefit of insulin delivery, and to make sure the pump is working properly.
Najbolje je redovito mjeriti razinu šećera u krvi kako bi se dobila maksimalna korist od primjene inzulina i kako biste osigurali da pumpa radi ispravno.
It is best to see how Adjupanrix affects you before you try these activities.
Prije nego počnete s tim aktivnostima, najbolje je vidjeti kako Adjupanrix djeluje na Vas.
It is best to take HETLIOZ on an empty stomach as food can reduce the amount of the medicine that is absorbed into your body.
Najbolje je uzeti HETLIOZ na prazan želudac jer hrana može smanjiti količinu lijeka koja se apsorbira u tijelo.
It is best to take your tablet with a meal.
Najbolje je tabletu uzeti uz obrok.
It is best to use Fuzeon at the same time each day.
Fuzeon je najbolje primjenjivati svakoga dana u isto vrijeme.
It is bound predominantly to albumin and to a lower extent to -1 acid glycoprotein.
Pretežno se veže na albumin, a u manjoj mjeri na -1-kiseli glikoprotein.
It is bound to the alpha-1- acid glycoprotein (AAG) and albumin, but has a higher affinity for AAG.
Vezan je za glikoprotein alfa-1- kiselina (AAG) i albumin, ali ima veći afinitet za AAG.
It is caused by a problem with your genes (called a “genetic mutation”) that affects the ability of cells in the eye to produce the energy they need to work normally, so they become inactive.
Uzrokovan je problemom u genima ("genetskom mutacijom") koja utječe na sposobnost stanica u oku da proizvode energiju koja im je potrebna za normalni rad, tako da postaju neaktivne.
It is caused by a thickening of the tissues under the skin of the palm that form ‘cords’ pulling down on the fingers.
Uzrokovane su zadebljanjem tkiva ispod kože dlana koji tvori „niti“ koje vuku prste prema dolje.
It is caused by various factors including bleeding and poor absorption of iron from food in the inflamed gut of these patients.
Prouzročena je različitim čimbenicima uključujući krvarenje i slabu apsorpciju željeza iz hrane u upaljenim crijevima tih bolesnika.
It is characterised by stiffness, muscle twitching, shaking, agitation and confusion, coma, high body temperature, increased heart rate and unstable blood pressure; a rare severe muscle disorder (rhabdomyolysis) which causes pain, tenderness and weakness of the muscles and may lead to kidney problems.
Karakteriziran je ukočenošću, trzanjem mišića, drhtavicom, uznemirenošću, smetenošću, komom, visokom tjelesnom temperaturom, povećanom brzinom otkucaja srca i nestabilnim krvnim tlakom; rijedak, teški mišićni poremećaj (rabdomioliza) koji uzrokuje bol, osjetljivost i slabost mišića i može dovesti do problema s bubrezima.
It is characterised by the deficiency of -galactosidase.
Karakterizira je nedostatak α-galaktozidaze.
It is clear, colourless to pale yellow, and does not contain flakes or particles.
Bistra je, bezbojna do blijedožuta i ne sadrži pahuljice ili čestice.
It is common to have medicine leftover in the cup.
Uobičajeno je da u čaši za miješanje ostane malo lijeka.
It is common to observe a slight increase of rectal temperature of up to 1.2 °C for 4 days post-vaccination in the absence of other generalised clinical signs.
Zabilježen je uobičajeni blagi porast rektalno izmjerene temperature do 1,2°C tijekom 4 dana nakon cijepljenja u odsutnosti drugih generaliziranih kliničkih simptoma.
It is completely soluble at the acidic pH of the Toujeo injection solution (pH 4).
Potpuno je topljiv u kiselom mediju kakav je Toujeo otopina za injekciju (pH 4).